Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 46% ± 16% | |
peripheral blood | 18 studies | 52% ± 15% | |
brain | 18 studies | 42% ± 20% | |
intestine | 10 studies | 42% ± 20% | |
kidney | 10 studies | 37% ± 14% | |
eye | 10 studies | 44% ± 16% | |
liver | 6 studies | 45% ± 23% | |
bone marrow | 5 studies | 43% ± 22% | |
uterus | 5 studies | 55% ± 19% | |
adipose | 5 studies | 32% ± 11% | |
lymph node | 5 studies | 53% ± 11% | |
pancreas | 4 studies | 46% ± 24% | |
heart | 4 studies | 32% ± 7% | |
breast | 4 studies | 50% ± 12% | |
placenta | 3 studies | 53% ± 6% | |
esophagus | 3 studies | 37% ± 27% | |
thymus | 3 studies | 54% ± 25% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 25365.95 | 459 / 459 | 100% | 109.56 | 1118 / 1118 |
esophagus | 100% | 23258.65 | 1445 / 1445 | 100% | 73.77 | 183 / 183 |
lung | 100% | 26433.13 | 578 / 578 | 100% | 75.92 | 1155 / 1155 |
ovary | 100% | 34099.06 | 180 / 180 | 100% | 52.34 | 430 / 430 |
stomach | 100% | 19180.96 | 359 / 359 | 100% | 65.86 | 286 / 286 |
uterus | 100% | 29055.96 | 170 / 170 | 100% | 85.63 | 459 / 459 |
brain | 100% | 20471.85 | 2639 / 2642 | 100% | 73.93 | 705 / 705 |
thymus | 100% | 26192.53 | 653 / 653 | 100% | 75.40 | 604 / 605 |
intestine | 100% | 24644.46 | 966 / 966 | 100% | 70.51 | 526 / 527 |
bladder | 100% | 26469.33 | 21 / 21 | 100% | 70.04 | 503 / 504 |
prostate | 100% | 22975.77 | 245 / 245 | 100% | 71.34 | 501 / 502 |
liver | 100% | 11175.62 | 226 / 226 | 100% | 42.66 | 405 / 406 |
skin | 100% | 26032.24 | 1809 / 1809 | 99% | 79.31 | 469 / 472 |
pancreas | 100% | 13606.94 | 327 / 328 | 99% | 56.91 | 177 / 178 |
kidney | 100% | 18240.42 | 89 / 89 | 99% | 54.10 | 890 / 901 |
adrenal gland | 100% | 24825.88 | 258 / 258 | 98% | 47.12 | 225 / 230 |
adipose | 100% | 25775.65 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 25936.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 88.18 | 29 / 29 |
spleen | 100% | 25665.80 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 77.63 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 33.20 | 1 / 1 |
muscle | 100% | 19185.63 | 802 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 59.25 | 79 / 80 |
heart | 98% | 14471.40 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 20984.99 | 908 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_2000373 | Biological process | positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity |
GO_0051301 | Biological process | cell division |
GO_0048255 | Biological process | mRNA stabilization |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0032211 | Biological process | negative regulation of telomere maintenance via telomerase |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0070934 | Biological process | CRD-mediated mRNA stabilization |
GO_0009048 | Biological process | dosage compensation by inactivation of X chromosome |
GO_0001649 | Biological process | osteoblast differentiation |
GO_1990280 | Biological process | RNA localization to chromatin |
GO_0000398 | Biological process | mRNA splicing, via spliceosome |
GO_2000767 | Biological process | positive regulation of cytoplasmic translation |
GO_1902275 | Biological process | regulation of chromatin organization |
GO_0055013 | Biological process | cardiac muscle cell development |
GO_0006396 | Biological process | RNA processing |
GO_1902889 | Biological process | protein localization to spindle microtubule |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_1990845 | Biological process | adaptive thermogenesis |
GO_0000380 | Biological process | alternative mRNA splicing, via spliceosome |
GO_0033673 | Biological process | negative regulation of kinase activity |
GO_1902425 | Biological process | positive regulation of attachment of mitotic spindle microtubules to kinetochore |
GO_0071385 | Biological process | cellular response to glucocorticoid stimulus |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006325 | Biological process | chromatin organization |
GO_1901673 | Biological process | regulation of mitotic spindle assembly |
GO_2000648 | Biological process | positive regulation of stem cell proliferation |
GO_0034244 | Biological process | negative regulation of transcription elongation by RNA polymerase II |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0051457 | Biological process | maintenance of protein location in nucleus |
GO_0090336 | Biological process | positive regulation of brown fat cell differentiation |
GO_2000737 | Biological process | negative regulation of stem cell differentiation |
GO_1900152 | Biological process | negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay |
GO_0098963 | Biological process | dendritic transport of messenger ribonucleoprotein complex |
GO_1990498 | Cellular component | mitotic spindle microtubule |
GO_0009986 | Cellular component | cell surface |
GO_0098577 | Cellular component | inactive sex chromosome |
GO_0070937 | Cellular component | CRD-mediated mRNA stability complex |
GO_0032839 | Cellular component | dendrite cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000922 | Cellular component | spindle pole |
GO_0072686 | Cellular component | mitotic spindle |
GO_0000228 | Cellular component | nuclear chromosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0030496 | Cellular component | midbody |
GO_0016020 | Cellular component | membrane |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_1990023 | Cellular component | mitotic spindle midzone |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0016607 | Cellular component | nuclear speck |
GO_0000776 | Cellular component | kinetochore |
GO_0005697 | Cellular component | telomerase holoenzyme complex |
GO_0016363 | Cellular component | nuclear matrix |
GO_0005829 | Cellular component | cytosol |
GO_0071013 | Cellular component | catalytic step 2 spliceosome |
GO_0017130 | Molecular function | poly(C) RNA binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0031490 | Molecular function | chromatin DNA binding |
GO_0003725 | Molecular function | double-stranded RNA binding |
GO_0001097 | Molecular function | TFIIH-class transcription factor complex binding |
GO_0017069 | Molecular function | snRNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0003727 | Molecular function | single-stranded RNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0003690 | Molecular function | double-stranded DNA binding |
GO_0043021 | Molecular function | ribonucleoprotein complex binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0003779 | Molecular function | actin binding |
GO_0034046 | Molecular function | poly(G) binding |
GO_0106222 | Molecular function | lncRNA binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0008143 | Molecular function | poly(A) binding |
GO_0003697 | Molecular function | single-stranded DNA binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003714 | Molecular function | transcription corepressor activity |
GO_0000993 | Molecular function | RNA polymerase II complex binding |
GO_0070034 | Molecular function | telomerase RNA binding |
GO_0099122 | Molecular function | RNA polymerase II C-terminal domain binding |
GO_0036002 | Molecular function | pre-mRNA binding |
Gene name | HNRNPU |
Protein name | Heterogeneous nuclear ribonucleoprotein U (hnRNP U) (GRIP120) (Nuclear p120 ribonucleoprotein) (Scaffold-attachment factor A) (SAF-A) (p120) (pp120) Heterogeneous nuclear ribonucleoprotein U |
Synonyms | U21.1 SAFA C1orf199 HNRPU |
Description | FUNCTION: DNA- and RNA-binding protein involved in several cellular processes such as nuclear chromatin organization, telomere-length regulation, transcription, mRNA alternative splicing and stability, Xist-mediated transcriptional silencing and mitotic cell progression . Plays a role in the regulation of interphase large-scale gene-rich chromatin organization through chromatin-associated RNAs (caRNAs) in a transcription-dependent manner, and thereby maintains genomic stability . Required for the localization of the long non-coding Xist RNA on the inactive chromosome X (Xi) and the subsequent initiation and maintenance of X-linked transcriptional gene silencing during X-inactivation (By similarity). Plays a role as a RNA polymerase II (Pol II) holoenzyme transcription regulator . Promotes transcription initiation by direct association with the core-TFIIH basal transcription factor complex for the assembly of a functional pre-initiation complex with Pol II in a actin-dependent manner . Blocks Pol II transcription elongation activity by inhibiting the C-terminal domain (CTD) phosphorylation of Pol II and dissociates from Pol II pre-initiation complex prior to productive transcription elongation . Positively regulates CBX5-induced transcriptional gene silencing and retention of CBX5 in the nucleus . Negatively regulates glucocorticoid-mediated transcriptional activation . Key regulator of transcription initiation and elongation in embryonic stem cells upon leukemia inhibitory factor (LIF) signaling (By similarity). Involved in the long non-coding RNA H19-mediated Pol II transcriptional repression . Participates in the circadian regulation of the core clock component BMAL1 transcription (By similarity). Plays a role in the regulation of telomere length . Plays a role as a global pre-mRNA alternative splicing modulator by regulating U2 small nuclear ribonucleoprotein (snRNP) biogenesis . Plays a role in mRNA stability . Component of the CRD-mediated complex that promotes MYC mRNA stabilization . Enhances the expression of specific genes, such as tumor necrosis factor TNFA, by regulating mRNA stability, possibly through binding to the 3'-untranslated region (UTR) . Plays a role in mitotic cell cycle regulation . Involved in the formation of stable mitotic spindle microtubules (MTs) attachment to kinetochore, spindle organization and chromosome congression . Phosphorylation at Ser-59 by PLK1 is required for chromosome alignement and segregation and progression through mitosis . Contributes also to the targeting of AURKA to mitotic spindle MTs . Binds to double- and single-stranded DNA and RNA, poly(A), poly(C) and poly(G) oligoribonucleotides . Binds to chromatin-associated RNAs (caRNAs) . Associates with chromatin to scaffold/matrix attachment region (S/MAR) elements in a chromatin-associated RNAs (caRNAs)-dependent manner . Binds to the Xist RNA . Binds the long non-coding H19 RNA . Binds to SMN1/2 pre-mRNAs at G/U-rich regions . Binds to small nuclear RNAs (snRNAs) . Binds to the 3'-UTR of TNFA mRNA . Binds (via RNA-binding RGG-box region) to the long non-coding Xist RNA; this binding is direct and bridges the Xist RNA and the inactive chromosome X (Xi) (By similarity). Also negatively regulates embryonic stem cell differentiation upon LIF signaling (By similarity). Required for embryonic development (By similarity). Binds to brown fat long non-coding RNA 1 (Blnc1); facilitates the recruitment of Blnc1 by ZBTB7B required to drive brown and beige fat development and thermogenesis (By similarity). .; FUNCTION: (Microbial infection) Negatively regulates immunodeficiency virus type 1 (HIV-1) replication by preventing the accumulation of viral mRNA transcripts in the cytoplasm. . |
Accessions | ENST00000704074.1 ENST00000638716.1 ENST00000444376.7 [Q00839-2] A0A1W2PPH7 ENST00000639880.1 A0A1W2PQ74 ENST00000640306.1 Q00839 A0A1W2PP35 ENST00000489705.2 ENST00000638230.1 A0A1W2PP34 ENST00000640001.1 ENST00000283179.14 ENST00000639628.2 A0A1W2PQL0 ENST00000639824.1 A0A1W2PPE9 A0A087WZF3 A0A1X7SBS1 Q5RI18 A0A087WVI9 ENST00000640056.1 ENST00000483966.3 A0A1W2PQD4 ENST00000640119.1 ENST00000638301.1 A0A1W2PRZ7 ENST00000440865.2 ENST00000638475.1 A0A1W2PRI6 ENST00000475997.6 ENST00000640440.1 A0A1W2PPL4 A0A1W2PNG3 A0A994J6V2 ENST00000640218.2 [Q00839-1] A0A1W2PPS1 A0A1W2PP22 |